TrialBlood advances2024

Ibrutinib plus rituximab and mini-CHOP in older patients with newly diagnosed DLBCL: a phase 2 ALLG study.

Emma Verner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.